SCHEMBL23058643

SCHEMBL23058643

CCCN(C(C)C)C(C)c1ccc(CO)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
ALOX5 P09917 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CSF1R P07333 2/20 0.33
EGFR P00533 1/20 0.33
DRD3 P35462 2/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23058480 0.79 AOC3 (0.38) SLC6A2SLC6A3
SCHEMBL23058147 0.78 THRA (0.33) THRATHRBESR1ESR2ALOX5
SCHEMBL11141687 0.74 ALOX5 (0.40) ESR1ESR2ALOX5CSF1REGFR
SCHEMBL23058486 0.72 DAGLA (0.42) HDAC1HDAC8HDAC6HRH3
SCHEMBL13784552 0.72 ESR1 (0.44) ESR1ESR2SLC6A2SLC6A3
SCHEMBL23059048 0.71 PDPK1 (0.33) DRD3
SCHEMBL23058487 0.71 PDE2A (0.47) SLC6A2SLC6A3HDAC1HDAC6
SCHEMBL16919625 0.70 ESR1 (0.58) ESR1ESR2SLC6A2SLC6A3HDAC8
SCHEMBL6447082 0.69 CSF1R (0.40) ALOX5CSF1REGFRHRH3
SCHEMBL12111408 0.69 ESR1 (0.41) ESR1ESR2SLC6A2SLC6A3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021041588-A1 SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-03-04 WO disclosed